LifT BioSciences Company

Cell therapy to destroy solid tumours through Neutrophil Only Leukocyte Infusion Therapy (N-LIfT)
Technology:
AgeTech Companies
Industry:
Healthcare
Headquarters:
United Kingdom
Founded Date:
2016
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
3
Total Funding:
2843855
Last Funding Date:
2019
Last Funding Type:
Series A
Register and Claim Ownership